Merck Once-Daily ARV Pill Could Reach Market Soon
Michael Gwarisa In a move that could significantly reduce pill burden and improve adherence to antiretroviral therapy (ART), the United States Food and Drug Administration has approved a new once-daily pill developed by Merck & Co. for adults living with HIV-1 who are already virologically suppressed. The pill is intended to replace a patient’s existing
Read MoreZimbabwe Secures US$12M ARVs Amid Funding Cuts – Shipment Arrives in June
By Kuda Pembere, recently in Chinhoyi With concerns mounting over potential shortages of antiretroviral drugs (ARVs) following the United States Government’s funding cuts, Health and Child Care Minister Douglas Mombeshora has reassured Zimbabweans that there will be no disruptions in supply. He confirmed that the government has already procured ARVs worth US$12 million, expected to
Read MorePSH Works to Restore HIV Services At All New Start Centres
By Kuda Pembere Population Solutions for Health (PSH) is working tirelessly to resume HIV services previously offered at New Start Centres, following a funding review initiated by the U.S. State Department under the administration of former President Donald Trump. The closure of New Start Centres is part of PSH’s compliance with the U.S. government directive.
Read MoreMeet Dr. Dhodho: The Once Sickly Village Boy Who Transformed Rural Zimbabwe’s HIV Response
By Michael Gwarisa He wears many hats. Dr. Efison Dhodho is currently the Knowledge Manager for the Zimbabwe College of Public Health Physicians, a dedicated researcher, and the Director for Strategic Information, Evaluation, Learning, and Information Technology Systems at the Organization for Public Health Interventions and Development (OPHID). Born into a family of 13 as
Read MorePOTRAZ Advises Zim To Use SMS And Voice Network For Health Communication Interventions… Says majority of Zimbabweans still using generic phones
The Mobile Revolution is here and Zimbabwe just like many other countries in the world has progressed in ensuring access to mobile phone services is affordable by anyone regardless of economic background. In Zimbabwe, even horses have cell-phones and there are probably more mobile phones than there are toothbrushes in the world. By Michael Gwarisa
Read MoreZimbabwe’s Aged Persons on ARVs at Greater Risk of NCDs
HIV and AIDS is slowly becoming an ageing issue in Zimbabwe with indications that majority of People Living with HIV (PLHIV) and on Antiretroviral Therapy (ART) are those above the age of 50 and are at greater risk of developing Non-Communicable Diseases (NCDs). By Michael Gwarisa Even though the country has been recording a number
Read MoreAfter Falling Off The Radar, Orphaned HIV Positive Boy Develops High Viral Load
A few minutes after bringing her son into this world, Simba Ncube’s* mother lost her life to AIDS related complications in 2010. Luckily before she died, Simba’s mother had registered her cousin sister, Ms Pride Ncube* as the next of kin and guardian to her child. On the fateful day, the hospital called Ms Ncube
Read MoreTowards an AIDS Free Generation, Nyazura Celebrates PMTCT Milestone
“GETTING initiated on Antiretroviral Therapy (ART) as well as registering for the Prevention of Mother to Child Transmission of HIV (PMTCT) program early has been the best decision I have ever made,” said Tracey Makoni* (27) from Nyazura, in Manicaland province during an interview with HealthTimes on a media tour that was organised by the
Read MorePSH rolls out HIV treatment literacy campaign, coined ‘Flip the Script’
Population Solutions for Health (PSH), formerly PSI Zimbabwe and the Ministry of Health and Child Care (MoHCC), launched “Flip the Script”, a campaign aimed at enhancing HIV treatment literacy and promoting adherence to ART (Antiretroviral Therapy) medication amongst PLHIV. By Patricia Mashiri The campaign is currently being implemented in three areas, namely, Nyabira in Zvimba
Read MoreNo Evidence Of Drug Interaction Between ARVs And COVID-19 Vaccines- MoHCC
THE Ministry of Health and Child Care (MoHCC) has says there is no possibility of drug interaction if a Person Living with HIV (PLHIV) takes the COVID-19 vaccine, hence persons with HIV and on Antiretroviral Therapy (ART) should not hesitate to get the jab. By Michael Gwarisa Speaking during a virtual Media Briefing on HIV
Read More